Copyright Reports & Markets. All rights reserved.

Global Biosimilars/follow-on-biologics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Biosimilars/follow-on-biologics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Human growth hormone
    • 1.4.3 Erythropoietin
    • 1.4.4 Monoclonal antibodies
    • 1.4.5 Insulin
    • 1.4.6 Interferon
    • 1.4.7 Granulocyte-Colony Stimulating Factor
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2026
    • 1.5.2 Blood disorders
    • 1.5.3 Oncology diseases
    • 1.5.4 Chronic and autoimmune diseases
    • 1.5.5 Growth hormone deficiencies
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Biosimilars/follow-on-biologics Market Perspective (2015-2026)
  • 2.2 Global Biosimilars/follow-on-biologics Growth Trends by Regions
    • 2.2.1 Biosimilars/follow-on-biologics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biosimilars/follow-on-biologics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Biosimilars/follow-on-biologics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Biosimilars/follow-on-biologics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Biosimilars/follow-on-biologics Players by Market Size
    • 3.1.1 Global Top Biosimilars/follow-on-biologics Players by Revenue (2015-2020)
    • 3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Biosimilars/follow-on-biologics Market Concentration Ratio
    • 3.2.1 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Biosimilars/follow-on-biologics Revenue in 2019
  • 3.3 Biosimilars/follow-on-biologics Key Players Head office and Area Served
  • 3.4 Key Players Biosimilars/follow-on-biologics Product Solution and Service
  • 3.5 Date of Enter into Biosimilars/follow-on-biologics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Biosimilars/follow-on-biologics Historic Market Size by Type (2015-2020)
  • 4.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
  • 5.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biosimilars/follow-on-biologics Market Size (2015-2020)
  • 6.2 Biosimilars/follow-on-biologics Key Players in North America (2019-2020)
  • 6.3 North America Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
  • 6.4 North America Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Biosimilars/follow-on-biologics Market Size (2015-2020)
  • 7.2 Biosimilars/follow-on-biologics Key Players in Europe (2019-2020)
  • 7.3 Europe Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
  • 7.4 Europe Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

8 China

  • 8.1 China Biosimilars/follow-on-biologics Market Size (2015-2020)
  • 8.2 Biosimilars/follow-on-biologics Key Players in China (2019-2020)
  • 8.3 China Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
  • 8.4 China Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Biosimilars/follow-on-biologics Market Size (2015-2020)
  • 9.2 Biosimilars/follow-on-biologics Key Players in Japan (2019-2020)
  • 9.3 Japan Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
  • 9.4 Japan Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Biosimilars/follow-on-biologics Market Size (2015-2020)
  • 10.2 Biosimilars/follow-on-biologics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

11 India

  • 11.1 India Biosimilars/follow-on-biologics Market Size (2015-2020)
  • 11.2 Biosimilars/follow-on-biologics Key Players in India (2019-2020)
  • 11.3 India Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
  • 11.4 India Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Biosimilars/follow-on-biologics Market Size (2015-2020)
  • 12.2 Biosimilars/follow-on-biologics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
  • 12.4 Central & South America Biosimilars/follow-on-biologics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Novartis (Sandoz)
    • 13.1.1 Novartis (Sandoz) Company Details
    • 13.1.2 Novartis (Sandoz) Business Overview
    • 13.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Introduction
    • 13.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2015-2020))
    • 13.1.5 Novartis (Sandoz) Recent Development
  • 13.2 Synthon Pharmaceuticals
    • 13.2.1 Synthon Pharmaceuticals Company Details
    • 13.2.2 Synthon Pharmaceuticals Business Overview
    • 13.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Introduction
    • 13.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
    • 13.2.5 Synthon Pharmaceuticals Recent Development
  • 13.3 Teva Pharmaceutical Industries
    • 13.3.1 Teva Pharmaceutical Industries Company Details
    • 13.3.2 Teva Pharmaceutical Industries Business Overview
    • 13.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Introduction
    • 13.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
    • 13.3.5 Teva Pharmaceutical Industries Recent Development
  • 13.4 LG Life Sciences
    • 13.4.1 LG Life Sciences Company Details
    • 13.4.2 LG Life Sciences Business Overview
    • 13.4.3 LG Life Sciences Biosimilars/follow-on-biologics Introduction
    • 13.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
    • 13.4.5 LG Life Sciences Recent Development
  • 13.5 Celltrion Biocon
    • 13.5.1 Celltrion Biocon Company Details
    • 13.5.2 Celltrion Biocon Business Overview
    • 13.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Introduction
    • 13.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
    • 13.5.5 Celltrion Biocon Recent Development
  • 13.6 Hospira
    • 13.6.1 Hospira Company Details
    • 13.6.2 Hospira Business Overview
    • 13.6.3 Hospira Biosimilars/follow-on-biologics Introduction
    • 13.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
    • 13.6.5 Hospira Recent Development
  • 13.7 Merck Serono (Merck)
    • 13.7.1 Merck Serono (Merck) Company Details
    • 13.7.2 Merck Serono (Merck) Business Overview
    • 13.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Introduction
    • 13.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
    • 13.7.5 Merck Serono (Merck) Recent Development
  • 13.8 Biogen idec
    • 13.8.1 Biogen idec Company Details
    • 13.8.2 Biogen idec Business Overview
    • 13.8.3 Biogen idec Biosimilars/follow-on-biologics Introduction
    • 13.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
    • 13.8.5 Biogen idec Recent Development
  • 13.9 Genentech (Roche)
    • 13.9.1 Genentech (Roche) Company Details
    • 13.9.2 Genentech (Roche) Business Overview
    • 13.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Introduction
    • 13.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
    • 13.9.5 Genentech (Roche) Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Biosimilars/follow-on-biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/follow-on-biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Novartis (Sandoz)
    Synthon Pharmaceuticals
    Teva Pharmaceutical Industries
    LG Life Sciences
    Celltrion Biocon
    Hospira
    Merck Serono (Merck)
    Biogen idec
    Genentech (Roche)

    Market segment by Type, the product can be split into
    Human growth hormone
    Erythropoietin
    Monoclonal antibodies
    Insulin
    Interferon
    Granulocyte-Colony Stimulating Factor
    Others
    Market segment by Application, split into
    Blood disorders
    Oncology diseases
    Chronic and autoimmune diseases
    Growth hormone deficiencies
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now